Sam Williams@biotech_CEO·28 Ağu@TurpinCharmaine I have your father's complete fighting record, as written out by his then trainer, I believe. Let me know if interested.Çevir English0000
charmaine turpin@TurpinCharmaine·7 AğuHave been busy helping organise the event, but annette says you are aware of it? Hope you can come and will try and pop by-keep saying thatÇevir English2040
Sam Williams@biotech_CEO·30 Haz@Dan_Mahony I will settle for 'seductive' 😬 twitter.com/Dan_Mahony/sta…ÇevirDaniel Mahony@Dan_MahonyRemember @biotech_CEO , they thought the company @modernbio was interesting - I think you will have to settle for inspirational twitter.com/ipgroupplc/sta… English0010
Sam Williams@biotech_CEO·15 Oca@_rjw @JohnCFierce @lisamjarvis Financial community also responsible, overlooking the clearly flawed P2 data and selective disclosure by CoÇevir English0020
Sam Williams retweetlediScientific American@sciam·17 NisWhy a journal just banned scientists from using p-values in their studies: ow.ly/LIHQf #science #researchÇevir English61661300
Sam Williams@biotech_CEO·15 Nis@portefeuillefun @DrugDiscoverer that's almost 30% out! But not bad I guess given I haven't been following this one before now. Thanks!Çevir English0000
Sam Williams@biotech_CEO·15 Nis@DrugDiscoverer @AndyBiotech hah. I'm just chancing my arm. Someone's gotta do itÇevir English0000
Sam Williams@biotech_CEO·15 Nis@AndyBiotech @DrugDiscoverer yep exactly right. Good ACR a given these days. Question is opp infections. And structural data. All in the P3Çevir English1100
Sam Williams@biotech_CEO·15 Nis@DrugDiscoverer @AndyBiotech $GLPG stock'll be up, regardless. 12%?Çevir English0000
Sam Williams@biotech_CEO·15 Nis@DrugDiscoverer @AndyBiotech @DrugDiscoverer @AndyBiotech Humira monoTx ACR 20 50 70 = 53% 35% 18% so actually pretty good by comparisonÇevir English1000
Sam Williams@biotech_CEO·15 Nis@DrugDiscoverer @AndyBiotech so only stat significant at ACR20 50 and 70 at the highest doses. Not sure it's ground-breaking.Çevir English0000
Sam Williams retweetlediDr. Kevin Campbell, MD, FACC, MBA@DrKevinCampbell·12 ŞubA drug rep showed up in my office today with this. Really?Çevir English1018120
Sam Williams@biotech_CEO·19 Oca@DrugDiscoverer That's a good question. It's all in the mix with OX-1...!Çevir English0010
Sam Williams retweetlediPhil Holliger@PhilHolliger·1 AraNew paper from my group at Nature AOP: nature.com/nature/journal…. XNAs can do catalysis: XNAzymes cleave RNA, ligate RNA and ligate XNAs.Çevir Filipino0550
Sam Williams retweetlediGeorge Freeman FRSA MP@MPGeorgeFreeman·9 AraUK Life Sciences Biomedical Catalyst funding cited as key to R&D alliance between Modern Biosciences Plc & Janssen Biotech @biotech_CEOÇevir English01150
Sam Williams@biotech_CEO·3 Ara@DrugDiscoverer Possibly, Lisa, as the JAKs simply haven't delivered, at least on safety. Must be some nervous cos developing JAKs out thereÇevir English0010
Sam Williams@biotech_CEO·1 Ara@JohnCFierce @DamianFierce @biotech_CEO great piece @DamianFierceÇevir English1010
Sam Williams retweetlediJohn Carroll@JohnCendpts·1 AraJ&J bets up to $277M on a prospect from its R&D farm system by @DamianFierce @biotech_CEO fiercebiotech.com/story/jj-bets-…Çevir English2530
Sam Williams@biotech_CEO·1 Ara@PDRennert @JohnCFierce Undisclosed, I'm afraid. However, I can say that we have a unique effect, acting directly on inflammation and boneÇevir English1000